Literature DB >> 8160766

Membranous nephropathy. Insights from Heymann nephritis.

T Cavallo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160766      PMCID: PMC1887245     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  75 in total

1.  Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities.

Authors:  Y Natori; I Hayakawa; S Shibata
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

2.  Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.

Authors:  D Kerjaschki; R Horvat; S Binder; M Susani; G Dekan; P P Ojha; P Hillemanns; W Ulrich; U Donini
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

3.  Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen.

Authors:  P C Hogendoorn; J A Bruijn; L J vd Broek; E De Heer; J M Foidart; P J Hoedemaeker; G J Fleuren
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

4.  Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.

Authors:  S Pietromonaco; D Kerjaschki; S Binder; R Ullrich; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Immunocytochemical and biochemical characterization of the Heymann nephritis antigenic complex in rat L2 yolk sac cells.

Authors:  M Lundstrom; R A Orlando; M S Saedi; L Woodward; H Kurihara; M G Farquhar
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  Characterization of the antigen (gp600) of Heymann nephritis.

Authors:  S P Makker; A K Singh
Journal:  Lab Invest       Date:  1984-03       Impact factor: 5.662

7.  Demonstration of a passive Heymann nephritis-like mechanism in a human kidney transplant.

Authors:  M Zanetti; C Mandet; A Duboust; J Bedrossian; J Bariety
Journal:  Clin Nephrol       Date:  1981-05       Impact factor: 0.975

8.  Characterization of antigens and antibody specificities involved in Heymann nephritis.

Authors:  K Kamata; L G Baird; M E Erikson; A B Collins; R T McCluskey
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Comparative histologic and immunologic studies in rabbits of induced hypersensitivity of the serum sickness type. II. The effect of sensitization to homologous and cross-reactive antigens on the rate of antigen elimination and the development of allergic lesions.

Authors:  F G GERMUTH; M G PACE; J C TIPPETT
Journal:  J Exp Med       Date:  1955-02-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

Review 2.  Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.

Authors:  M G Farquhar
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Authors:  D Kerjaschki; M Exner; R Ullrich; M Susani; L K Curtiss; J L Witztum; M G Farquhar; R A Orlando
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis.

Authors:  M Exner; M Susani; J L Witztum; A Hovorka; L K Curtiss; S Spitzauer; D Kerjaschki
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  SLE and Serum Complement: Causative, Concomitant or Coincidental?

Authors:  Vaneet Sandhu; Michele Quan
Journal:  Open Rheumatol J       Date:  2017-09-30

Review 6.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

7.  Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Authors:  Warren Raymond; Gro Eilertsen; Johannes Nossent
Journal:  J Immunol Res       Date:  2018-12-30       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.